Published in Int J Radiat Oncol Biol Phys on June 15, 2013
Preliminary results of a phase II trial of proton radiotherapy for pediatric rhabdomyosarcoma. J Clin Oncol (2014) 1.63
New challenges in high-energy particle radiobiology. Br J Radiol (2014) 1.08
A dosimetric comparison of proton and intensity modulated radiation therapy in pediatric rhabdomyosarcoma patients enrolled on a prospective phase II proton study. Radiother Oncol (2014) 0.96
Proton radiobiology. Cancers (Basel) (2015) 0.89
Promise and pitfalls of heavy-particle therapy. J Clin Oncol (2014) 0.85
Cardiac avoidance in breast radiotherapy: many choices for a worthwhile objective. Front Oncol (2014) 0.81
Recommendations for the referral of patients for proton-beam therapy, an Alberta Health Services report: a model for Canada? Curr Oncol (2014) 0.80
Subsequent malignancies after photon versus proton radiation therapy. Int J Radiat Oncol Biol Phys (2013) 0.79
Early toxicity in patients treated with postoperative proton therapy for locally advanced breast cancer. Int J Radiat Oncol Biol Phys (2015) 0.78
Proton beam therapy for pediatric malignancies: a retrospective observational multicenter study in Japan. Cancer Med (2016) 0.78
Comparative Risk Predictions of Second Cancers After Carbon-Ion Therapy Versus Proton Therapy. Int J Radiat Oncol Biol Phys (2016) 0.77
Lifetime increased cancer risk in mice following exposure to clinical proton beam-generated neutrons. Int J Radiat Oncol Biol Phys (2014) 0.76
Proton therapy in the management of non-Hodgkin lymphoma. Leuk Lymphoma (2015) 0.76
Long-term outcomes and prognostic factors of skull-base chondrosarcoma patients treated with pencil-beam scanning proton therapy at the Paul Scherrer Institute. Neuro Oncol (2015) 0.76
The Impact of Neutrons in Clinical Proton Therapy. Front Oncol (2015) 0.75
Proton therapy - Present and future. Adv Drug Deliv Rev (2016) 0.75
Secondary Malignancy Risk Following Proton Radiation Therapy. Front Oncol (2015) 0.75
Proton beam therapy for localized prostate cancer 101: basics, controversies, and facts. Rev Urol (2014) 0.75
Proton therapy for early stage prostate cancer: is there a case? Onco Targets Ther (2016) 0.75
Range modulation in proton therapy planning: a simple method for mitigating effects of increased relative biological effectiveness at the end-of-range of clinical proton beams. Radiat Oncol (2014) 0.75
Protons, Photons, and the Prostate - Is There Emerging Evidence in the Ongoing Discussion on Particle Therapy for the Treatment of Prostate Cancer? Front Oncol (2016) 0.75
A critical appraisal of the clinical utility of proton therapy in oncology. Med Devices (Auckl) (2015) 0.75
Comparative study of the effects of different radiation qualities on normal human breast cells. Radiat Oncol (2017) 0.75
Analysis of patient outcomes following proton radiation therapy for retinoblastoma. Adv Radiat Oncol (2017) 0.75
AMP-activated protein kinase induces a p53-dependent metabolic checkpoint. Mol Cell (2005) 11.19
Patients' expectations about effects of chemotherapy for advanced cancer. N Engl J Med (2012) 10.93
Addition of ifosfamide and etoposide to standard chemotherapy for Ewing's sarcoma and primitive neuroectodermal tumor of bone. N Engl J Med (2003) 8.48
Immunogenicity of induced pluripotent stem cells. Nature (2011) 7.31
Comparative effectiveness of minimally invasive vs open radical prostatectomy. JAMA (2009) 7.25
p53 induces differentiation of mouse embryonic stem cells by suppressing Nanog expression. Nat Cell Biol (2004) 5.82
Intratumoral balance of regulatory and cytotoxic T cells is associated with prognosis of hepatocellular carcinoma after resection. J Clin Oncol (2007) 5.28
The "gender gap" in authorship of academic medical literature--a 35-year perspective. N Engl J Med (2006) 5.23
Utilization and outcomes of minimally invasive radical prostatectomy. J Clin Oncol (2008) 4.23
Serum DKK1 as a protein biomarker for the diagnosis of hepatocellular carcinoma: a large-scale, multicentre study. Lancet Oncol (2012) 4.21
Associations between palliative chemotherapy and adult cancer patients' end of life care and place of death: prospective cohort study. BMJ (2014) 3.90
p53 gain-of-function cancer mutants induce genetic instability by inactivating ATM. Nat Cell Biol (2007) 3.86
Place of death: correlations with quality of life of patients with cancer and predictors of bereaved caregivers' mental health. J Clin Oncol (2010) 3.78
Cost sharing and adherence to tyrosine kinase inhibitors for patients with chronic myeloid leukemia. J Clin Oncol (2013) 3.70
Overexpression of PD-L1 significantly associates with tumor aggressiveness and postoperative recurrence in human hepatocellular carcinoma. Clin Cancer Res (2009) 3.39
Effectiveness of primary androgen-deprivation therapy for clinically localized prostate cancer. J Clin Oncol (2014) 3.17
Outcomes of a pilot faculty mentoring program. Am J Obstet Gynecol (2004) 2.82
Functional analysis of the roles of posttranslational modifications at the p53 C terminus in regulating p53 stability and activity. Mol Cell Biol (2005) 2.72
Cardiovascular status in long-term survivors of Hodgkin's disease treated with chest radiotherapy. J Clin Oncol (2004) 2.68
The association of race/ethnicity, insurance status, and socioeconomic factors with breast cancer care. Cancer (2010) 2.63
Involvement of receptor-interacting protein 2 in innate and adaptive immune responses. Nature (2002) 2.60
Variation in patient-sharing networks of physicians across the United States. JAMA (2012) 2.59
A population-based assessment of specialty physician involvement in cancer clinical trials. J Natl Cancer Inst (2011) 2.48
Molecular symmetry in mitochondrial cardiolipins. Chem Phys Lipids (2005) 2.23
Unexpected role of interferon-γ in regulating neuronal connectivity and social behaviour. Nature (2016) 2.21
Modeling disease in human ESCs using an efficient BAC-based homologous recombination system. Cell Stem Cell (2010) 2.19
Immediate risk of suicide and cardiovascular death after a prostate cancer diagnosis: cohort study in the United States. J Natl Cancer Inst (2010) 2.18
Trends in mammography screening rates after publication of the 2009 US Preventive Services Task Force recommendations. Cancer (2013) 2.14
Evidence-based risk communication: a systematic review. Ann Intern Med (2014) 2.14
Ser18 and 23 phosphorylation is required for p53-dependent apoptosis and tumor suppression. EMBO J (2006) 2.12
A targeted intervention for the career development of women in academic medicine. Arch Intern Med (2007) 2.09
The Effect of Erythropoietin-Stimulating Agents on Health-Related Quality of Life in Anemia of Chronic Kidney Disease: A Systematic Review and Meta-analysis. Ann Intern Med (2016) 2.09
End-of-life care discussions among patients with advanced cancer: a cohort study. Ann Intern Med (2012) 2.08
Cytotoxicity effects of graphene and single-wall carbon nanotubes in neural phaeochromocytoma-derived PC12 cells. ACS Nano (2010) 2.05
Androgen-deprivation therapy in prostate cancer and cardiovascular risk: a science advisory from the American Heart Association, American Cancer Society, and American Urological Association: endorsed by the American Society for Radiation Oncology. CA Cancer J Clin (2010) 2.05
Cell type- and promoter-specific roles of Ser18 phosphorylation in regulating p53 responses. J Biol Chem (2003) 2.02
Survival of older patients with cancer in the Veterans Health Administration versus fee-for-service Medicare. J Clin Oncol (2012) 2.00
Associations between end-of-life discussion characteristics and care received near death: a prospective cohort study. J Clin Oncol (2012) 1.95
Medulloblastoma: tumorigenesis, current clinical paradigm, and efforts to improve risk stratification. Nat Clin Pract Oncol (2007) 1.94
Second malignancy after Hodgkin disease treated with radiation therapy with or without chemotherapy: long-term risks and risk factors. Blood (2002) 1.90
The role of primary care physicians in cancer care. J Gen Intern Med (2009) 1.87
Association of autophagy defect with a malignant phenotype and poor prognosis of hepatocellular carcinoma. Cancer Res (2008) 1.85
A snapshot of smokers after lung and colorectal cancer diagnosis. Cancer (2012) 1.85
Circulating stem cell-like epithelial cell adhesion molecule-positive tumor cells indicate poor prognosis of hepatocellular carcinoma after curative resection. Hepatology (2013) 1.84
Explaining racial differences in prostate cancer mortality. Cancer (2012) 1.82
Discussions with physicians about hospice among patients with metastatic lung cancer. Arch Intern Med (2009) 1.77
Proteomic fingerprints for potential application to early diagnosis of severe acute respiratory syndrome. Clin Chem (2004) 1.76
VAMP and low-dose, involved-field radiation for children and adolescents with favorable, early-stage Hodgkin's disease: results of a prospective clinical trial. J Clin Oncol (2002) 1.76
Medicare Part D and nursing home residents. J Am Geriatr Soc (2007) 1.74
Differences in clinical trial patient attributes and outcomes according to enrollment setting. J Clin Oncol (2009) 1.74
Retracted Carbon nanotubes are able to penetrate plant seed coat and dramatically affect seed germination and plant growth. ACS Nano (2009) 1.73
Is spending more always wasteful? The appropriateness of care and outcomes among colorectal cancer patients. Health Aff (Millwood) (2008) 1.70
Prospective study of health-related quality of life for children with brain tumors treated with proton radiotherapy. J Clin Oncol (2012) 1.70
Mapping physician networks with self-reported and administrative data. Health Serv Res (2011) 1.70
Trends in racial and age disparities in definitive local therapy of early-stage breast cancer. J Clin Oncol (2008) 1.69
Medical oncologists' perceptions of financial incentives in cancer care. J Clin Oncol (2012) 1.69
Coexistence of hepatitis B surface antigen (HBsAg) and heterologous subtype-specific antibodies to HBsAg among patients with chronic hepatitis B virus infection. Clin Infect Dis (2007) 1.69
National Institutes of Health state-of-the-science conference statement: Enhancing use and quality of colorectal cancer screening. Ann Intern Med (2010) 1.67
Factors influencing changes in employment among women with newly diagnosed breast cancer. Cancer (2009) 1.66
Androgen-deprivation therapy for nonmetastatic prostate cancer is associated with an increased risk of peripheral arterial disease and venous thromboembolism. Eur Urol (2012) 1.65
Mutation of mouse p53 Ser23 and the response to DNA damage. Mol Cell Biol (2002) 1.65
A DNA nanostructure platform for directed assembly of synthetic vaccines. Nano Lett (2012) 1.64
Targeted disruption of NBS1 reveals its roles in mouse development and DNA repair. EMBO J (2002) 1.64
Phosphorylation site interdependence of human p53 post-translational modifications in response to stress. J Biol Chem (2003) 1.63
Rejections of drug claims for nursing home residents under Medicare Part D. Health Aff (Millwood) (2008) 1.63
Essential roles of the kappa light chain intronic enhancer and 3' enhancer in kappa rearrangement and demethylation. Nat Immunol (2002) 1.63
Geographic variation in cancer-related imaging: Veterans Affairs health care system versus Medicare. Ann Intern Med (2014) 1.62
Understanding variation in primary prostate cancer treatment within the Veterans Health Administration. Urology (2012) 1.62
The representation of women on the editorial boards of major medical journals: a 35-year perspective. Arch Intern Med (2008) 1.60
Permanent alopecia after cranial irradiation: dose-response relationship. Int J Radiat Oncol Biol Phys (2004) 1.58
Long-term survival and competing causes of death in patients with early-stage Hodgkin's disease treated at age 50 or younger. J Clin Oncol (2002) 1.58
Cardiolipin affects the supramolecular organization of ATP synthase in mitochondria. Biophys J (2011) 1.57
Phosphorylation stabilizes Nanog by promoting its interaction with Pin1. Proc Natl Acad Sci U S A (2010) 1.57
Pharmacokinetics of ertapenem in patients with varying degrees of renal insufficiency and in patients on hemodialysis. J Clin Pharmacol (2006) 1.56
Role of overexpression of CD151 and/or c-Met in predicting prognosis of hepatocellular carcinoma. Hepatology (2009) 1.56
Physician patient-sharing networks and the cost and intensity of care in US hospitals. Med Care (2012) 1.56
Liver-intestine cadherin predicts microvascular invasion and poor prognosis of hepatitis B virus-positive hepatocellular carcinoma. Cancer (2009) 1.54
Phase II study of thalidomide in patients with unresectable hepatocellular carcinoma. Cancer (2005) 1.54
p53 and stem cells: new developments and new concerns. Trends Cell Biol (2010) 1.53
Does oral antiandrogen use before leuteinizing hormone-releasing hormone therapy in patients with metastatic prostate cancer prevent clinical consequences of a testosterone flare? Urology (2009) 1.52
Role of calcium-independent phospholipase A2 in the pathogenesis of Barth syndrome. Proc Natl Acad Sci U S A (2009) 1.51
Proteomic characteristics of human sperm cryopreservation. Proteomics (2014) 1.51
Variegation mutants and mechanisms of chloroplast biogenesis. Plant Cell Environ (2007) 1.50
Real-time rationing of scarce resources: the Northeast Proton Therapy Center experience. J Clin Oncol (2004) 1.46
Acetylation of mouse p53 at lysine 317 negatively regulates p53 apoptotic activities after DNA damage. Mol Cell Biol (2006) 1.45
The hepatitis B virus X protein disrupts innate immunity by downregulating mitochondrial antiviral signaling protein. J Immunol (2010) 1.44
Treatment of metastatic Ewing sarcoma/primitive neuroectodermal tumor of bone: evaluation of increasing the dose intensity of chemotherapy--a report from the Children's Oncology Group. Pediatr Blood Cancer (2007) 1.43
Atomic structure, energetics, and dynamics of topological solitons in indium chains on Si(111) surfaces. Phys Rev Lett (2011) 1.42
A randomized controlled trial of an automated exercise coach for older adults. J Am Geriatr Soc (2013) 1.42
Puma is required for p53-induced depletion of adult stem cells. Nat Cell Biol (2010) 1.41
A genomewide study identifies the Wnt signaling pathway as a major target of p53 in murine embryonic stem cells. Proc Natl Acad Sci U S A (2009) 1.41
Ultrasensitive measurement of hotspot mutations in tumor DNA in blood using error-suppressed multiplexed deep sequencing. Cancer Res (2012) 1.39
Treatment of metastatic Ewing's sarcoma or primitive neuroectodermal tumor of bone: evaluation of combination ifosfamide and etoposide--a Children's Cancer Group and Pediatric Oncology Group study. J Clin Oncol (2004) 1.37
Up-regulation of Krüppel-like factor 8 promotes tumor invasion and indicates poor prognosis for hepatocellular carcinoma. Gastroenterology (2010) 1.37
A dosimetric comparison of proton and intensity-modulated photon radiotherapy for pediatric parameningeal rhabdomyosarcomas. Int J Radiat Oncol Biol Phys (2008) 1.34